Arkolith/Insider Trading/PEAR/Form 4

McCann Corey

President and CEO, DirectorPear Therapeutics, Inc. (PEAR) · full profile →Form 4 · filed Jan 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2023Option exercise(M)88K—$08.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2023Option exercise(M)88K—$0179K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-001039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML